American Journal of Cardiology
Volume 105, Issue 1 , Pages 36-42 , 1 January 2010

Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction

  • Erlend Aune, MD

      Affiliations

    • Department of Cardiology, Vestfold Hospital Trust, Toensberg, Norway
    • Corresponding Author InformationCorresponding author: (+47) 33-34-20-00; fax: (+47) 33-34-39-50
    • ,
  • Knut Endresen, MD, PhD

      Affiliations

    • Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway
    • ,
  • Keith A.A. Fox, MB, ChB

      Affiliations

    • Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom
    • ,
  • Jon Erik Steen-Hansen, MD

      Affiliations

    • Prehospital Clinic, Vestfold Hospital Trust, Toensberg, Norway
    • ,
  • Jo Roislien, MSc, PhD

      Affiliations

    • Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
    • Morbid Obesity Center, Vestfold Hospital Trust, Toensberg, Norway
    • ,
  • Joran Hjelmesaeth, MD, PhD

      Affiliations

    • Morbid Obesity Center, Vestfold Hospital Trust, Toensberg, Norway
    • ,
  • Jan Erik Otterstad, MD, PhD

      Affiliations

    • Department of Cardiology, Vestfold Hospital Trust, Toensberg, Norway

Received 12 June 2009 ,Revised 11 August 2009 ,Accepted 11 August 2009.

References 

  1. Aune E, Hjelmesaeth J, Fox KA, Endresen K, Otterstad JE. High mortality rates in conservatively managed patients with acute coronary syndrome. Scand Cardiovasc J. 2006;40:137–144
  2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20
  3. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial (Randomized Intervention Trial of unstable Angina). Lancet. 2002;360:743–751
  4. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293:2908–2917
  5. O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71–80
  6. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA. 2007;297:1892–1900
  7. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847
  8. Myocardial infarction redefined—a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–1513
  9. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333:1091–1094
  10. Vestfold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2003;10:429–437
  11. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23:1809–1840
  12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2002;40:1366–1374
  13. Boersma E. Does time matter? (A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients). Eur Heart J. 2006;27:779–788
  14. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733–742
  15. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J. 2003;24:94–104
  16. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165–2175
  17. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E FRISC II Investigators. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial (Fast Revascularisation during Instability in Coronary artery disease). Lancet. 2000;356:9–16
  18. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353:1095–1104
  19. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  20. Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotzsche LB, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2005;26:18–26
  21. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Smoking and myocardial infarction. Lancet. 1975;1:415–420
  22. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO CASS Investigators. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. J Am Coll Cardiol. 1992;20:287–294
  23. Barone-Adesi F, Vizzini L, Merletti F, Richiardi L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J. 2006;27:2468–2472
  24. Centers for Disease Control and Prevention. Reduced hospitalizations for acute myocardial infarction after implementation of a smoke-free ordinance—City of Pueblo, Colorado, 2002–2006. MMWR Morb Mortal Wkly Rep. 2009;57:1373–1377
  25. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482–491
  26. Statistics Norway 2009. www.ssb.no/english/subjects/03/01/10/dodsarsak_en/Accessed September 12, 2008
  27. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502

 This work was supported by research grants from South-East Norway Regional Health Authority and Vestfold Hospital Trust, Toensberg, Norway.

PII: S0002-9149(09)02206-1

doi: 10.1016/j.amjcard.2009.08.641

American Journal of Cardiology
Volume 105, Issue 1 , Pages 36-42 , 1 January 2010

Article Tools

* Image Usage & Resolution